官方服务：
资源简介：
Revenue of Veracyte from 2020 to 2024 (in million U.S. dollars)
应用场景：
相关数据集
Chromosomal microarray data for validation of copy-number variants detection from a low-coverage whole-genome sequencing approach in clinical samples
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
NIAID Data Ecosystem70
Additional file 2: of Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients
Tier 1 and tier 2 genes included in v1 of the panel. (XLSX 13 kb)
Figshare2018-11-08 更新60
Patients b'*' with intermediate- and high-risk lesions that were up-classified by Percepta GSC and underwent additional procedures prior to malignant diagnosis.
Patientsb'*' with intermediate- and high-risk lesions that were up-classified by Percepta GSC and underwent additional procedures prior to malignant diagnosis.
NIAID Data Ecosystem50
Beam Therapeutics revenue 2021-2025
Revenue of Beam Therapeutics from 2021 to 2025 (in million U.S. dollars)
Statista70
Additional file 1 of Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases
Additional file 1. Supplementary Tables (Tables S1-S14).
Figshare2021-10-14 更新50
